Read Dr. Noc, PhD with Scottie
Keep Dr. Noc, PhD. Lose the inbox pileup.
Scottie reads the newsletters you choose, keeps the useful differences, and attaches every original link. Dr. Noc, PhD stays in your reading life without becoming another email to manage.
An independent guide. Scottie isn't affiliated with, endorsed by, or sponsored by Dr. Noc, PhD. The publication owns its name, writing, and subscription terms.
From Scottie · July 31, 2026
See Dr. Noc, PhD in a Scottie brief
Scottie read Dr. Noc, PhD, Dr. Jessica Knurick, and Your Local Epidemiologist for a reader with the priorities shown below. Start with the rundown, open the full brief, or check every issue behind it.
3sources
7issues read
4stories included
2 of 3 Dr. Noc, PhD issues included
What shaped this brief
Reader priorities
A reader who wants infectious-disease and medical-product claims checked plainly before they spread through a feed.
These are illustrative priorities, not a customer’s data.
Sources in this brief
- Dr. Noc, PhDThe publication this guide is about
- Dr. Jessica KnurickAdds health-policy, agency, food-safety, and medical-product updates.
- Your Local EpidemiologistAdds outbreak, vaccine, and public-health context.
Scottie
Scottie example brief
July 31, 2026 · Executive brief
01 / The rundown
- FDA advisors recommended allowing pharmacy compounding for six peptides despite zero human trial data, confusing compounding access with formal drug approval.
- US measles cases hit a 35-year record of 2,318 infections, while a massive Cyclospora outbreak tied to lettuce exceeded 14,000 cases.
Read the complete brief 4 stories · 2 action items
02 / The briefing
01 / main
FDA panel backs peptide compounding, not drug approval
The takeaway: Viral claims that the FDA approved peptide injections like BPC-157 or TB-500 are wrong. An advisory panel voted to allow compounding pharmacies to mix six peptides, overriding career FDA scientists who opposed all seven due to missing human safety data.
Concrete details
- Career FDA scientists found zero published human studies for TB-500, MOTS-c, or KPV before the panel voted.
- Only 7.9% of drug development programs entering Phase 1 clinical trials ultimately earn official FDA approval.
Why it matters for this reader: Spotting the difference between pharmacy compounding permission and full FDA approval keeps you from spreading hyped safety claims on social media feeds.
Original sourcesDr. Noc, PhD
02 / main
Alzheimer's blood tests promise future answers but lack clearance
The takeaway: Headlines claiming new p-tau217 blood tests predict a 78% Alzheimer's risk obscure vital fine print. The FDA cleared these tests strictly to evaluate patients already showing cognitive symptoms, not as predictive tools for healthy individuals.
Concrete details
- p-tau217 test results boosted primary care diagnostic accuracy from 65% to 93% for patients with memory symptoms.
- Nearly 23.5% of asymptomatic adults in their seventies carry Alzheimer's brain changes without developing cognitive decline.
Why it matters for this reader: Demystifying exaggerated diagnostic claims helps you debunk viral mail-order test hype before unverified screening advice spreads through your feed.
Original sourcesDr. Noc, PhD
03 / main
Measles cases hit 35-year record as summer waves rise
The takeaway: US measles cases reached 2,318 this year across 35 outbreaks, setting a 35-year record driven primarily by unvaccinated returning travelers. Meanwhile, Cyclospora cases linked to iceberg lettuce topped 14,000 as summer Covid-19 ED visits ticked upward.
Concrete details
- Three in four index measles cases stem from US citizens contracting the virus while traveling abroad.
- Egg recalls cover over 19 million units stamped with plant codes P-1950 or 0840962 and Julian dates 157-184.
Why it matters for this reader: Having plain, verified statistics allows you to quickly check sensationalized outbreak claims before sharing public health updates with others.
Original sourcesYour Local Epidemiologist
04 / main
Public health fatigue complicates evaluating weekly health threats
The takeaway: Rapidly emerging disease reports combined with low institutional trust create a confusing cycle of panic. Cuts to public health infrastructure and sensationalized media coverage make evaluating genuine individual risk increasingly difficult for the public.
Concrete details
- A flood of recent health alerts spans hantavirus, measles, Ebola, Cyclospora, screwworm, West Nile virus, and wildfire smoke.
Why it matters for this reader: Understanding how click-driven media amplifies minor health scares helps you filter out noise and factual exaggerations in your daily feed.
Original sourcesYour Local Epidemiologist
Action items
- Check your fridge for recalled eggs stamped with plant codes P-1950 or 0840962 and throw them away immediately.
- Advise contacts against buying mail-order p-tau217 Alzheimer's tests without symptoms, as medical guidelines explicitly oppose healthy screening.
See every issue behind this brief
Debunking FDA Approval Claims for Peptide Injections
- No, the FDA did not "approve" those peptidesDr. Noc, PhD · Included
Tracking US Measles, Foodborne Illness, and Covid-19 Waves
- Measles record (and hot questions), foodborne illness summer, Covid-19 summer wave, and moreYour Local Epidemiologist · Included
FDA committee peptides
- FDA Committee Backs Peptides, Cyclospora Reaches Record Levels, and a New Bill Proposes Universal Healthcare for KidsDr. Jessica Knurick · Read, not included
Evaluating Alzheimer's Risk Blood Test Claims
- The Truth About the "78% Alzheimer's Risk" Blood TestDr. Noc, PhD · Included
Understanding Public Health Risk Tracking and Communication
- Why is gauging health risk so hard?Your Local Epidemiologist · Included
Author background inquiry
- welcome to the Quack ZoneDr. Noc, PhD · Read, not included
Harassment incident
- It's time to leave the man alone.Your Local Epidemiologist · Read, not included
About Dr. Noc, PhD
Should you add Dr. Noc, PhD to Scottie?
Separate documented medical evidence from viral misinformation and regulatory misstatements.[1][2][3]
Who it’s for
A reader who wants infectious-disease and medical-product claims checked plainly before they spread through a feed.[1][2]
What you’ll find in it
The issues linked below include “Hantavirus: what to know”, “No, the FDA did not "approve" those peptides”, and “welcome to the Quack Zone”. Open them to judge the publication in its own words.
- Byline
- Morgan McSweeney[1]
How to read Dr. Noc, PhD with Scottie
Add its public feed for publicly available issues. If you subscribe to paid issues, forward those emails to your private @scottie.fyi address. Scottie does not need access to your inbox.
Scottie read 3 Dr. Noc, PhD items and included 2 for the brief. The sources covered different things, so Scottie kept their stories separate instead of forcing a connection.
Read three issues from Dr. Noc, PhD
Read the publication in its own words. Scottie keeps these original links attached; it does not replace the writing.
- Hantavirus: what to knowPublic issue[2]
- No, the FDA did not "approve" those peptidesPublic issue[3]
- welcome to the Quack ZoneMon, 27 Jul 2026[4]